Literature DB >> 4997690

Interaction between ABO and rhesus blood groups, the site of origin of gastric cancers, and the age and sex of the patient.

G A Glober, E G Cantrell, R Doll, R Peto.   

Abstract

ABO and Rhesus blood group data have been examined for 1,680 patients treated for gastric cancer in four London hospitals. The risk of developing gastric cancer was estimated to be 16% higher for group A subjects than for group O subjects, in close agreement with many previous reports throughout the world. More detailed analysis failed to support the suggestion that there was any special correlation between either ABO or Rhesus blood groups and the site of origin of the tumour within the stomach or the sex or age of the patient. Male predominance among the patients was noted to be greater at ages 40-69 years than at other ages and greater for tumours of the upper two thirds of the stomach than for tumours that arose distally.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4997690      PMCID: PMC1411870          DOI: 10.1136/gut.12.7.570

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  Observations on blood group distribution in peptic ulcer and gastric cancer.

Authors:  R DOLL; B F SWYNNERTON; A C NEWELL
Journal:  Gut       Date:  1960-03       Impact factor: 23.059

3.  Blood groups of gastric ulcer and carcinoma.

Authors:  W H BEASLEY
Journal:  Br Med J       Date:  1960-04-16

4.  The association of the ABO blood groups to gastric carcinoma.

Authors:  J A BUCKWALTER; C B WOHLWEND; D C COLTER; R T TIDRICK; L A KNOWLER
Journal:  Surg Gynecol Obstet       Date:  1957-02

5.  Gastric cancer; relationships between ABO blood-groups, site, and epidemiology.

Authors:  B P BILLINGTON
Journal:  Lancet       Date:  1956-10-27       Impact factor: 79.321

6.  Carcinoma of stomach in relation to ABO blood-groups.

Authors:  D JENNINGS; R H BALME; J E RICHARDSON
Journal:  Lancet       Date:  1956-07-07       Impact factor: 79.321

7.  The blood groups in relation to peptic ulceration and carcinoma of colon, rectum, breast, and bronchus; an association between the ABO groups and peptic ulceration.

Authors:  I AIRD; H H BENTALL; J A MEHIGAN; J A F ROBERTS
Journal:  Br Med J       Date:  1954-08-07

8.  The capillary tube method of rhesus testing with a report on blood group frequencies in North West London.

Authors:  G DISCOMBE; H MEYER
Journal:  Am J Clin Pathol       Date:  1952-06       Impact factor: 2.493

9.  Distribution of ABO blood groups in patients with pernicious anemia, gastric carcinoma and gastric carcinoma associated with pernicious anemia.

Authors:  L C Hoskins; H A Loux; A Britten; N Zamcheck
Journal:  N Engl J Med       Date:  1965-09-16       Impact factor: 91.245

10.  The sex ratio in gastric cancer and hypothetical considerations relative to aetiology.

Authors:  G W Griffith
Journal:  Br J Cancer       Date:  1968-06       Impact factor: 7.640

View more
  4 in total

Review 1.  Occupation and gastric cancer.

Authors:  A Raj; J F Mayberry; T Podas
Journal:  Postgrad Med J       Date:  2003-05       Impact factor: 2.401

2.  Role of bacterial and genetic factors in gastric cancer in Costa Rica.

Authors:  Sergio A Con; Hiroaki Takeuchi; Gil R Con-Chin; Vicky G Con-Chin; Nobufumi Yasuda; Reinaldo Con-Wong
Journal:  World J Gastroenterol       Date:  2009-01-14       Impact factor: 5.742

Review 3.  Prognostic factors for gastric cancer influencing clinical practice.

Authors:  J D Harrison; J W Fielding
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

4.  ABO blood group system and gastric cancer: a case-control study and meta-analysis.

Authors:  Zhiwei Wang; Lei Liu; Jun Ji; Jianian Zhang; Min Yan; Jun Zhang; Bingya Liu; Zhenggang Zhu; Yingyan Yu
Journal:  Int J Mol Sci       Date:  2012-10-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.